Clinical Trials Directory

Trials / Unknown

UnknownNCT03016780

Fecal Microbiota Transplantation for Ulcerative Colitis

Evaluation of The Effect of Fecal Microbiota Transplantation on Ulcerative Colitis and Its Mechanism

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
First Affiliated Hospital of Chengdu Medical College · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Ulcerative colitis is a common digestive system disease, the incidence is increasing in recent years.It is reported that the occurrence and development of ulcerative colitis is closely related to imbalance of intestinal flora .Moreover,intestinal mucosal immunity may be related to intestinal flora. Fecal microbiota transplantation as a new technology to rebuild intestinal flora has been used for several disease,but the efficacy of ulcerative colitis by fecal microbiota transplantation needs to be further explored.

Detailed description

Patients who meet the inclusion crit ulcerative colitisby will be separated into two parts depending on accepation or refuse of Fecal microbiota transplantation.Blood specimen from patients will be collected to analysis intestinal mucosal immunity.

Conditions

Interventions

TypeNameDescription
OTHERFecal Microbiota TransplantationFecal microbiota transplantation and the traditional treatments for ulcerative colitis in part 1.
OTHERNormal SalineNormal saline and the traditional treatments for ulcerative colitisin in part 2.

Timeline

Start date
2016-07-01
Primary completion
2018-07-01
Completion
2019-07-01
First posted
2017-01-11
Last updated
2017-01-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03016780. Inclusion in this directory is not an endorsement.